SCHEMBL2156462

SCHEMBL2156462

Cc1c(-c2ccc(OCCN3CCOCC3)cc2)ccc2nc(-c3cccnc3)nc(N)c12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ ACHE P22303 3/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ TNK2 Q07912 1/20 0.44
▸ PRKAB2 O43741 3/20 0.43
▸ PRKAG1 P54619 3/20 0.43
▸ PRKAA2 P54646 3/20 0.43
▸ PRKAA1 Q13131 3/20 0.43
▸ PRKAG3 Q9UGI9 3/20 0.43
▸ PRKAG2 Q9UGJ0 3/20 0.43
▸ PRKAB1 Q9Y478 3/20 0.43
▸ FLT1 P17948 2/20 0.43
▸ FLT4 P35916 2/20 0.43
▸ KDR P35968 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2154778 0.76 CYP1A2 (0.57) NPC1RAB9AACHEMEN1LMNA
SCHEMBL16186207 0.74 CYP11B2 (0.48) —
SCHEMBL16183288 0.72 CYP11B1 (0.40) NPC1RAB9ALMNACYP1A2CYP3A4
SCHEMBL27904606 0.70 AVPR1B (0.49) NPC1RAB9AMEN1LMNACYP1A2
SCHEMBL16183286 0.70 CHRNB2 (0.47) NPC1RAB9ALMNACYP1A2CYP3A4
SCHEMBL29557223 0.70 ACHE (0.57) NPC1RAB9AACHETNK2PRKAB2
SCHEMBL30586331 0.70 CHRNB2 (0.78) NPC1RAB9ACYP1A2CYP3A4CYP2D6
SCHEMBL16183287 0.69 CHRNB2 (0.49) MEN1LMNACYP1A2CYP3A4KMT2A
SCHEMBL14474103 0.68 CYP1A2 (0.51) MEN1LMNACYP1A2CYP3A4CYP2D6
SCHEMBL8812226 0.68 NPC1 (0.60) NPC1RAB9ACYP1A2LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2521549-A1 THERAPEUTIC COMPOUNDS AND RELATED METHODS OF USE Otsuka Pharmaceutical Co., Ltd. (JP) 2012-11-14 — — EP disclosed
WO-2011082337-A1 THERAPEUTIC COMPOUNDS AND RELATED METHODS OF USE GALENEA CORP. (US) 2011-07-07 — — WO disclosed
Send feedback